country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-187584

Copy Link Print Information

LQZ-7

LQZ-7 is a survivin inhibitor and molecular glue degrader (K_d=0.24 μM). LQZ-7 binds to the dimerization interface of survivin, disrupting homodimerization and dissociating dimeric survivin into monomers, thereby accelerating its proteasome-dependent degradation. LQZ-7 does not affect the structurally similar dimeric proteins 14-3-3σ and 14-3-3δ, and can induce apoptosis, exhibiting cytotoxicity against cancer cells.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No.: 1044664-73-4
화학식: C₂₄H₁₉N₇O₄
분자량:469.45

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

LQZ-7 Chemical Structure

CAS No.: 1044664-73-4

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

Cellular Effect

Cell Line	Type	Value	Description	References
PC-3	IC50	25 μM	Inhibitory concentration 50% against human PC-3 cancer cells assessed as reduction in cell survival incubated for 3 days by MTT assay. Inhibitory concentration 50% against human PC-3 cancer cells assessed as reduction in cell survival incubated for 3 days by MTT assay.	26744521
DU-145	IC50	25 μM	Inhibitory concentration 50% against human DU145 cancer cells assessed as reduction in cell survival incubated for 3 days by MTT assay. Inhibitory concentration 50% against human DU145 cancer cells assessed as reduction in cell survival incubated for 3 days by MTT assay.	26744521

In Vitro

Bacterial InfectionAnti-cancerApoptosis

Bacterial Infection

LQZ-7 (30 min) dissociates existing dimeric survivin^[1].
LQZ-7 (25 µM; 3 days) inhibits survival of PC-3 and DU145 cells with an IC₅₀ of ~25 µM^[1].

Anti-cancer

LQZ-7 (10 µM; 24 hours) induced survivin loss in PC-3 cells is reversed by proteasome inhibitors^[1].
LQZ-7 induces proteasome-dependent degradation of survivin in cancer cells^[2].

Apoptosis

Anti-cancer

LQZ-7 (20 μM) binds to survivin, disrupts survivin dimerization, and accelerates proteasome-dependent degradation of survivin, exhibiting cytotoxicity against Du145 and PC3 cells with an IC₅₀ of ~25 μM^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

DU145 and PC-3
Concentration:

25 µM
Incubation Time:

3 days
Result:

Inhibited survival of human PC-3 and DU145 cells with an IC50 of ~25 µM.

Western Blot Analysis^[1]

Cell Line:

PC-3
Concentration:

10 µM
Incubation Time:

24 hours
Result:

Induced survivin loss that was reversed by co-treatment with a proteasome inhibitor, MG132 or bortezomib.

In Vivo

Anti-cancer

LQZ-7F (25 mg/kg; i.p.; every 3 days; 8 doses) effectively inhibits the growth of PC-3 xenograft tumors in vivo by inducing apoptosis and reducing survivin levels^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

NOD/SCID (male, 4-6 weeks old)^[1]
Dosage:

25 mg/kg
Administration:

i.p.; every 3 days; 8 doses
Result:

Inhibited the growth of PC-3 xenograft tumors compared to the vehicle control.
Reduced final average tumor weight significantly compared to the control group.
Maintained constant body weight after multiple dosings.
Induced apoptosis, showing more apoptotic cells with condensed chromatin.
Dramatically reduced survivin levels as determined by Western blot and immunohistochemistry.

Related Protocols :

Chemical Information

CAS No. 1044664-73-4
분자량 469.45
화학식 C₂₄H₁₉N₇O₄
SMILES

OC(C1=CC=CC(C2=CC=C(O2)/C=N/NC3=NC4=NON=C4N=C3NC5=C(C(C)=CC=C5)C)=C1)=O
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Qi J, et al. Effective Targeting of the Survivin Dimerization Interface with Small-Molecule Inhibitors. Cancer research. 2016 Jan 15;76(2):453-62.

[2]. Martínez-García D, et al. Therapeutic strategies involving survivin inhibition in cancer. Medicinal research reviews. 2019 May;39(3):887-909.

[3]. Li F, et al. Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?. Journal of experimental & clinical cancer research : CR. 2019 Aug 22;38(1):368.

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기

Amount: USD 0.00

Biological Activity
- 제품 설명
- In Vitro
- In Vivo
Chemical Information
순도&문서
References

상품명:
Cat. No.:
수량:
MCE Japan Authorized Agent:

상품명:
CAS No.:
Species:
Purity:
수량:

LQZ-7